P Virkkunen
Overview
Explore the profile of P Virkkunen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiedler S, Bravin A, Keyrilainen J, Fernandez M, Suortti P, Thomlinson W, et al.
Phys Med Biol
. 2004 Apr;
49(2):175-88.
PMID: 15083665
Different modalities for imaging cancer-bearing breast tissue samples are described and compared. The images include clinical mammograms and computed tomography (CT) images, CT images with partly coherent synchrotron radiation (SR),...
2.
Osterlund P, Elomaa I, Virkkunen P, Joensuu H
Oncology
. 2001 Aug;
61(2):113-9.
PMID: 11528249
Objectives: The aim of the study was to define the maximum tolerated dose (MTD) of the combination of raltitrexed plus carmofur, and to evaluate the tolerability and efficacy of this...
3.
Saarto T, Blomqvist C, Virkkunen P, Elomaa I
J Clin Oncol
. 2001 Jan;
19(1):10-7.
PMID: 11134190
Purpose: Bisphosphonates have effectively reduced the development and progression of bone metastases in advanced breast cancer. The aim of this study was to determine whether bone metastases could be prevented...
4.
Popov P, Tukiainen E, Huuhtanen R, Virolainen M, Virkkunen P, Blomqvist C
Eur J Surg Oncol
. 2000 Nov;
26(7):679-85.
PMID: 11078615
Aims: The aims of this retrospective follow-up study were to evaluate the justification for limb-saving multi-disciplinary treatment of soft tissue sarcomas (STS) and to report the results achieved by our...
5.
Elomaa I, Risteli L, Laakso M, Lahtinen R, Virkkunen P, Risteli J
Eur J Cancer
. 1996 Jun;
32A(7):1166-70.
PMID: 8758248
In our previous double-blind trial, we reported that clodronate reduced the incidence of bone lesions, fractures, pain and hypercalcaemia in multiple myeloma. Recently, it has been assumed that the antiresorptive...
6.
Blomqvist C, Risteli L, Risteli J, Virkkunen P, Sarna S, Elomaa I
Br J Cancer
. 1996 May;
73(9):1074-9.
PMID: 8624266
Thirty-six patients with bone metastases included in a trial of supportive calcitonin on the treatment response to systemic therapy were monitored by conventional radiography, conventional indicators of bone metabolism [alkaline...
7.
Wiklund T, Huuhtanen R, Blomqvist C, Tukiainen E, Virolainen M, Virkkunen P, et al.
Eur J Cancer
. 1996 Feb;
32A(2):269-73.
PMID: 8664040
In 1987, a multidisciplinary soft tissue sarcoma (STS) group was established and a treatment protocol was set up. By 1993, there were 193 patients with a diagnosis of STS of...
8.
Laakso M, Lahtinen R, Virkkunen P, Elomaa I
Br J Haematol
. 1994 Aug;
87(4):725-9.
PMID: 7986713
Osteolytic lesions and pathological fractures are the major problems in the clinical management of multiple myeloma. We previously reported the main results of a randomized, controlled multicentre trial in 350...
9.
Virkkunen P, Hedberg P, Palvimo J, Birr E, Porvari K, Ruokonen M, et al.
Biochem Biophys Res Commun
. 1994 Jul;
202(1):49-57.
PMID: 8037752
Structural comparison of human and rat prostate-specific acid phosphatase (hPAP and rPAP) genes indicate that the exon number is different between these species. The hPAP gene contains 10 exons, whereas...
10.
Farkkila M, Jaaskelainen J, Kallio M, Blomstedt G, Raininko R, Virkkunen P, et al.
Br J Cancer
. 1994 Jul;
70(1):138-41.
PMID: 8018525
The effect of intratumoral recombinant interferon gamma (rIFN-gamma) as adjuvant to open cytoreduction and external irradiation of 60 Gy on survival in adults with a newly diagnosed high-grade cerebral glioma...